- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04196686
Ice Immersion Using Virtual Reality & Augmented Reality
February 28, 2022 updated by: Samuel Rodriguez, Stanford University
Evaluating the Effectiveness of Immersive Technologies, Virtual Reality and Augmented Reality, to Increase Pain Threshold During Ice Immersion.
The purpose of this study is to evaluate the effectiveness of different technologies, Virtual Reality and Augmented Reality with modifications as passive content, active content, cognitive load modulation, and positive encouragement coaching to increase the pain threshold as assessed by immersing a hand in ice water.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
185
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Greater than 18 years of age
- English speaking
- Hearing intact
Exclusion Criteria:
- Patients who do not consent
- Currently taking beta blockers or other chronotropic heart medication(s)
- Have a history of severe motion sickness
- Currently have nausea
- Currently experiencing seizures
- Are clinically unstable
- Have taken pain medications in the last 12 hours
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Ice bath Control then VR/AR
Participants will be randomized with a 1:1 allocation to use their dominant or non-dominant hand with VR or control (no VR) for the cold pressor test and then crossed over.
Participants will not be told of the specifics of the time limit, to avoid competitiveness and expectations and will be asked for pain scores every 30 seconds.
|
VR/AR headset with either passive or active content such as playing a game or watching a movie
Participants immerse hand in ice bath and starting again with their original assigned group and keep hand submerged as long as they can withstand the cold or until 4 minutes have elapsed, whichever comes first.
Participants will not be told of the specifics of the time limit, to avoid competitiveness and expectations and will be asked for pain scores every 30 seconds.
|
EXPERIMENTAL: Ice bath with VR/AR then Control
Participants will be randomized with a 1:1 allocation to use their dominant or non-dominant hand with VR or control (no VR) for the cold pressor test and then crossed over.
Participants will not be told of the specifics of the time limit, to avoid competitiveness and expectations and will be asked for pain scores every 30 seconds.
|
VR/AR headset with either passive or active content such as playing a game or watching a movie
Participants immerse hand in ice bath and starting again with their original assigned group and keep hand submerged as long as they can withstand the cold or until 4 minutes have elapsed, whichever comes first.
Participants will not be told of the specifics of the time limit, to avoid competitiveness and expectations and will be asked for pain scores every 30 seconds.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
VR Effect on Pain Tolerence
Time Frame: Duration of ice bath (approximately 0 - 4 minutes)
|
Given that the cold pressor test produces an uncomfortable experience, we considered longer duration within the ice bath to represent increased pain tolerance.
Measured in seconds (s).
|
Duration of ice bath (approximately 0 - 4 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
VR's Effect on Perceived Pain Intensity
Time Frame: Duration of ice bath (approximately 0 - 4 minutes)
|
During ice bath data collection participants will be asked to report pain on a numeric rating scale from 0-10, 0 being no pain and 10 being most excruciating pain imaginable every 30 seconds during ice bath
|
Duration of ice bath (approximately 0 - 4 minutes)
|
Skin Conductance Response Density (SCRD)
Time Frame: Duration of ice bath (approximately 0 - 4 minutes)
|
The effects of VR on modulating sympathetic response in the presence of painful stimuli, was assessed by analyzing SCRD per 30 second interval.
We refer to each of these 30 second intervals as a separate epoch.
Skin conductance is expected to increase with increasing sympathetic nervous system activity, as sympathetic activity increases sweat secretion to increase skin conductance.
|
Duration of ice bath (approximately 0 - 4 minutes)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 24, 2019
Primary Completion (ACTUAL)
March 4, 2021
Study Completion (ACTUAL)
March 4, 2021
Study Registration Dates
First Submitted
November 19, 2019
First Submitted That Met QC Criteria
December 11, 2019
First Posted (ACTUAL)
December 12, 2019
Study Record Updates
Last Update Posted (ACTUAL)
March 25, 2022
Last Update Submitted That Met QC Criteria
February 28, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 50951
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain, Acute
-
Rajavithi HospitalCompletedTotal Abdominal Hysterectomy ,Pain , Acute Postoperative,Gabapentin , CelecoxibThailand
-
Schulthess KlinikNot yet recruiting
-
Seoul National University HospitalNot yet recruiting
-
Chung-Ang University Gwangmyeong HospitalRecruitingPostoperative Pain, AcuteKorea, Republic of
-
TC Erciyes UniversityCompletedPostoperative Pain, AcuteTurkey
-
Umraniye Education and Research HospitalNot yet recruiting
-
Sohag UniversityCompletedPostoperative Pain, AcuteEgypt
-
Cairo UniversityNot yet recruitingPostoperative Pain, Acute
-
Armed Forces College of Medicine, Cairo, EgyptNot yet recruiting
-
Federal State Budgetary Organization, Federal Center...Completed
Clinical Trials on VR/AR
-
NYU Langone HealthRecruitingTraumatic Brain InjuryUnited States
-
Kaohsiung Medical University Chung-Ho Memorial...Recruiting
-
Fundación para el Fomento de la Investigación Sanitaria...Enrolling by invitationMedication Errors and Other Product Use Errors and IssuesSpain
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedVirtual Reality | Augmented Reality | Oral Care PerformanceTaiwan
-
Taipei Medical University HospitalUnknown
-
ALTality, Inc.National Institute on Drug Abuse (NIDA); M.D. Anderson Cancer Center; Baylor...Active, not recruitingSurgery | Pediatric CancerUnited States
-
Aerie PharmaceuticalsCompletedDiabetic Macular Edema | Neovascular Age-related Macular DegenerationUnited States
-
San Diego State UniversityNational Institute of Mental Health (NIMH)Completed
-
Massachusetts General HospitalAmerican Psychological Foundation; The Hilda & Preston Davis FoundationCompletedAvoidant/Restrictive Food Intake Disorder (ARFID)United States